US Stock MarketDetailed Quotes

RLYB Rallybio

Watchlist
  • 0.970
  • -0.022-2.17%
Trading Nov 18 15:06 ET
40.24MMarket Cap-617P/E (TTM)

About Rallybio Company

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.

Company Profile

SymbolRLYB
Company NameRallybio
Listing DateJul 29, 2021
Issue Price13.00
Founded2018
CEODr. Stephen Uden, M.D.
MarketNASDAQ
Employees43
Fiscal Year Ends12-31
Address234 Church Street,Suite 1020
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06510
Phone1-203-859-3820
Websitehttp://www.rallybio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Stephen Uden, M.D.
  • Chief Executive Officer, President and Director
  • 1.78M
  • Dr. Steven Ryder, M.D.
  • Chief Medical Officer
  • 1.27M
  • Jonathan I. Lieber, M.B.A.
  • Principal Accounting Officer, Chief Financial Officer and Treasurer
  • 1.91M
  • Dr. Martin W. Mackay, PhD
  • Executive Chairman of the Board
  • 1.78M
  • Dr. Hui Liu, M.B.A.,PhD
  • Independent Director
  • 111.45K
  • Ronald M. Hunt, M.B.A.
  • Independent Director
  • 115.45K
  • Dr. Lucian Iancovici, M.D.
  • Independent Director
  • 111.45K
  • Helen M. Boudreau, M.B.A.
  • Independent Director
  • 118.95K
  • Christine A. Nash, M.B.A.
  • Independent Director
  • 108.95K
  • Dr. Wendy K. Chung, M.D.,PhD
  • Independent Director
  • 95.00K
  • Paula Soteropoulos
  • Lead Independent Director
  • 113.95K
  • Dr. Robert Hopfner, M.B.A.,PhD,R.Ph.
  • Independent Director
  • 115.45K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data